Anzeige
Mehr »
Freitag, 03.10.2025 - Börsentäglich über 12.000 News
Golden Cross macht sich bereit: 1.350 Goldabbaustellen, 55 Ladder-Ziele und ein historischer Volltreffer
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JNRG | ISIN: US05350V1061 | Ticker-Symbol: 8HH
Tradegate
01.10.25 | 16:24
9,750 Euro
+0,52 % +0,050
1-Jahres-Chart
AVANOS MEDICAL INC Chart 1 Jahr
5-Tage-Chart
AVANOS MEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
9,5509,80014:27
9,5509,80009:41

Aktuelle News zur AVANOS MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
18.09.Avanos Medical Buys Nexus Medical to Bolster Critical Care Portfolio1
16.09.Avanos Acquires Nexus Medical To Enhance Medication Delivery1
15.09.Avanos Medical Acquires Nexus Medical To Expand Specialty Nutrition Systems Business1
15.09.Avanos Medical acquires Nexus Medical to enhance critical care solutions1
15.09.AVANOS MEDICAL, INC. - 8-K, Current Report2
AVANOS MEDICAL Aktie jetzt für 0€ handeln
15.09.Avanos Medical Acquires Nexus Medical to Strengthen Nutrition and Medication Delivery in Critical Care89ALPHARETTA, Ga., Sept. 15, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the acquisition of Nexus...
► Artikel lesen
10.09.Reasons to Retain Avanos Medical Stock in Your Portfolio Now1
06.08.Avanos Medical Stock Down as Q2 Earnings Miss Estimates, Margins Down1
05.08.AVANOS MEDICAL, INC. - 10-Q, Quarterly Report1
05.08.Avanos maintains $665M-$685M revenue target amid HA divestiture and tariff impact3
05.08.Avanos Q2 2025: Umsatz wächst, doch Gewinneinbruch lässt Aktie abstürzen1
05.08.Avanos Q2 2025 slides: Revenue grows while profits decline, shares tumble1
05.08.AVANOS MEDICAL, INC. - 8-K, Current Report1
05.08.Avanos Medical Non-GAAP EPS of $0.17 beats by $0.02, revenue of $175M beats by $9.5M1
05.08.Avanos Medical Announces Appointment of Scott Galovan as Senior Vice President, Chief Financial Officer; David Pacitti Appointed to Board of Directors80ALPHARETTA, Ga., Aug. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the appointment of Scott...
► Artikel lesen
05.08.Avanos Medical, Inc. Announces Second Quarter 2025 Results100ALPHARETTA, Ga., Aug. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2025 financial results. "Building off our first...
► Artikel lesen
31.07.Avanos announces divestiture of Hyaluronic Acid product line to Channel-Markers Medical5
16.07.Avanos Medical (AVNS) Appoints Camille Chang Gilmore as SVP and Chief Human Resources Officer1
18.06.AVANOS MEDICAL, INC. - S-8, Securities to be offered to employees in employee benefit plans1
09.06.Former Boston Scientific DEI, HR leader joins Avanos Medical as chief HR officer13
Weiter >>
33 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1